Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13462

Full metadata record

DC Field	Value	Language
dc.contributor.author	Gaikwad, Anil Bhanudas	-
dc.date.accessioned	2023-12-20T09:30:07Z	-
dc.date.available	2023-12-20T09:30:07Z	-
dc.date.issued	2017-08	-
dc.identifier.uri	https://www.sciencedirect.com/science/article/abs/pii/S1734114016302110	-
dc.identifier.uri	http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13462	-
dc.description.abstract	Non-alcoholic fatty liver disease (NAFLD), a chronic metabolic disorder is associated with oxidative stress, inflammation and fibrotic cascades. In this study, we aimed to examine the effects of Esculetin, a well-known anti-oxidant on TGF-β1 mediated liver fibrosis and FoxO1 activity.	en_US
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.subject	Pharmacy	en_US
dc.subject	Esculetin	en_US
dc.subject	Non-alcoholic fatty liver disease (NAFLD)	en_US
dc.subject	Liver fibrosis	en_US
dc.subject	Hepatic fibrosis	en_US
dc.title	Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway	en_US
dc.type	Article	en_US
Appears in Collections:	Department of Pharmacy

Files in This Item:

There are no files associated with this item.